{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:59:06Z","timestamp":1790643546661,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Malaria remains a major public health challenge in Ethiopia. While Plasmodium falciparum has historically been associated with severe disease, the clinical importance of Plasmodium vivax is increasingly recognized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to determine the prevalence, species distribution, severity, associated factors, and clinical outcomes of malaria among adults attending emergency departments in Central Ethiopia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A mixed retrospective-prospective observational study was conducted in the adult emergency departments of two tertiary hospitals from October 1 to December 31, 2025. Severe malaria was defined according to the 2014 World Health Organization (WHO) criteria. The association between malaria species and severe malaria was examined using bivariate logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 318 laboratory-confirmed malaria cases, P. vivax was the predominant species (49.7%), followed by P. falciparum (38.4%) and mixed infections (11.9%). Severe malaria was diagnosed in 65.7% of patients, with severe anaemia (haemoglobin\u2009&lt;\u20095\u00a0g\/dL) being the most common severity criterion (33.3%). Severe malaria occurred in 65.2% of patients with P. vivax and 67.2% with P. falciparum. No statistically significant association was found between malaria species and severe malaria. Most patients (62.3%) were discharged from the emergency department, while 27.7% were admitted to medical wards. In-hospital mortality was 4.4%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>P. vivax was the predominant malaria species among adults presenting to the two tertiary hospitals, and both P. vivax and P. falciparum were associated with substantial severe disease. Severe anaemia was the most common manifestation. Strengthening early diagnosis, prompt treatment, species-specific case management, and appropriate radical cure for P. vivax remains important for malaria control and elimination efforts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial statement<\/jats:title>\n                    <jats:p>This manuscript does not describe a clinical trial.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-14383-3","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:36:36Z","timestamp":1790098596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Emerging predominance of Plasmodium vivax and its contribution to severe malaria in Central Ethiopia: a mixed retrospective-prospective study from two tertiary hospitals"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7916-779X","authenticated-orcid":false,"given":"Ayto Addisu","family":"Negash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehreteab T.","family":"Woudineh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kassim H.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyob Z.","family":"Chafamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon Y.","family":"Tilahun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biruk G.","family":"Awata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraraw E.","family":"Dires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashagre E.","family":"Hundeto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsegenet D.","family":"Dires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adey A.","family":"Bogale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tekiy M.","family":"Bedore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"14383_CR1","unstructured":"World malaria report. 2025 [Internet]. [cited 2026 Aug 15]. Available from: https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2025."},{"key":"14383_CR2","unstructured":"Malaria. - Ethiopia [Internet]. [cited 2026 Aug 15]. Available from: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2024-DON542."},{"issue":"9","key":"14383_CR3","doi-asserted-by":"publisher","first-page":"e0009781","DOI":"10.1371\/JOURNAL.PNTD.0009781","volume":"15","author":"T Ketema","year":"2021","unstructured":"Ketema T, Bacha K, Getahun K, Del Portillo HA, Bassat Q. Plasmodium vivax epidemiology in Ethiopia 2000\u20132020: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2021;15(9):e0009781. https:\/\/doi.org\/10.1371\/JOURNAL.PNTD.0009781. PubMed PMID: 34525091.","journal-title":"PLoS Negl Trop Dis"},{"key":"14383_CR4","unstructured":"Malaria. 2024 Ethiopia country profile [Internet]. [cited 2026 Aug 15]. Available from: https:\/\/www.who.int\/publications\/m\/item\/malaria-2024-eth-country-profile."},{"key":"14383_CR5","doi-asserted-by":"publisher","unstructured":"Lake MW, Asemahagn MA, Nigussie TZ, Gelaye KA, Muchie KF, Engedaw HA, et al. Resurgence of malaria in the Amhara Region, Ethiopia (2014\u20132024): trends, spatial expansion, and control challenges. Malar J. 2025;24(1). https:\/\/doi.org\/10.1186\/S12936-025-05668-0. PubMed PMID: 41286876.","DOI":"10.1186\/S12936-025-05668-0"},{"key":"14383_CR6","doi-asserted-by":"publisher","unstructured":"Endalu T, Mohammed M, Bulcha I, Ushu L, Befkadu Z, Tamiru E, et al. A five-year (2020\u20132024) malaria surveillance data analysis of Mattu Karl Specialized Comprehensive Hospital, Oromia region, Southwest Ethiopia. Malar J. 2026;25(1). https:\/\/doi.org\/10.1186\/S12936-026-05788-1. PubMed PMID: 41578266.","DOI":"10.1186\/S12936-026-05788-1"},{"key":"14383_CR7","doi-asserted-by":"publisher","unstructured":"Teshome Z, Animut A, Negash Y, Giday M, Aklilu E. A six years trend analysis of malaria prevalence in Central Ethiopia Region. Malar J. 2026;25(1). https:\/\/doi.org\/10.1186\/S12936-026-05873-5. PubMed PMID: 41872891.","DOI":"10.1186\/S12936-026-05873-5"},{"key":"14383_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/B978-0-12-397900-1","volume":"80","author":"NM Anstey","year":"2012","unstructured":"Anstey NM, Douglas NM, Poespoprodjo JR, Price RN. Plasmodium vivax: clinical spectrum, risk factors and pathogenesis. Adv Parasitol. 2012;80:151\u2013201. https:\/\/doi.org\/10.1016\/B978-0-12-397900-1. 00003-7 PubMed PMID: 23199488.","journal-title":"Adv Parasitol"},{"key":"14383_CR9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/B978-0-12-397900-1","volume":"80","author":"NM Douglas","year":"2012","unstructured":"Douglas NM, John GK, von Seidlein L, Anstey NM, Price RN. Chemotherapeutic strategies for reducing transmission of Plasmodium vivax malaria. Adv Parasitol. 2012;80:271\u2013300. https:\/\/doi.org\/10.1016\/B978-0-12-397900-1. 00005-0 PubMed PMID: 23199490.","journal-title":"Adv Parasitol"},{"issue":"1","key":"14383_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12879-016-1780-Z","volume":"16","author":"Y Demissie","year":"2016","unstructured":"Demissie Y, Ketema T. Complicated malaria symptoms associated with Plasmodium vivax among patients visiting health facilities in Mendi town, Northwest Ethiopia. BMC Infect Dis 2016. 2016;16(1):1. https:\/\/doi.org\/10.1186\/S12879-016-1780-Z . PubMed PMID: 27549864.","journal-title":"BMC Infect Dis 2016"},{"issue":"1","key":"14383_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12936-024-05171-Y","volume":"23","author":"A Abossie","year":"2024","unstructured":"Abossie A, Getachew H, Demissew A, Habtamu K, Tsegaye A, Zhong D, et al. Profiling vivax malaria incidence, residual transmission, and risk factors using reactive case detection in low transmission settings of Ethiopia. Malar J 2024. 2024;23(1):1. https:\/\/doi.org\/10.1186\/S12936-024-05171-Y. PubMed PMID: 39609814.","journal-title":"Malar J 2024"},{"key":"14383_CR12","doi-asserted-by":"publisher","unstructured":"Assemie A. Malaria prevalence and distribution of plasmodium species in Southern Region of Ethiopia. J Parasitol Res. 2022;2022:5665660. https:\/\/doi.org\/10.1155\/2022\/5665660. PubMed PMID: 35782658.","DOI":"10.1155\/2022\/5665660"},{"issue":"6 Suppl","key":"14383_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4269\/ajtmh.2007.77.79","volume":"77","author":"RN Price","year":"2007","unstructured":"Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM. Vivax malaria: neglected and not benign. Am J Trop Med Hyg. 2007;77(6 Suppl):79. https:\/\/doi.org\/10.4269\/ajtmh.2007.77.79. PubMed PMID: 18165478.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"14383_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1128\/CMR.00074-12","volume":"26","author":"J Kevin Baird","year":"2013","unstructured":"Kevin Baird J. Evidence and implications of mortality associated with acute Plasmodium vivax malaria. Clin Microbiol Rev. 2013;26(1):36\u201357. https:\/\/doi.org\/10.1128\/CMR.00074-12. PubMed PMID: 23297258.","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"14383_CR15","doi-asserted-by":"publisher","first-page":"0881","DOI":"10.1371\/JOURNAL.PMED.0050127","volume":"5","author":"B Genton","year":"2008","unstructured":"Genton B, D\u2019Acremont V, Rare L, Baea K, Reeder JC, Alpers MP, et al. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med. 2008;5(6):0881\u20139. https:\/\/doi.org\/10.1371\/JOURNAL.PMED.0050127. PubMed PMID: 18563961.","journal-title":"PLoS Med"},{"issue":"6","key":"14383_CR16","doi-asserted-by":"publisher","first-page":"0890","DOI":"10.1371\/JOURNAL.PMED.0050128","volume":"5","author":"E Tjitra","year":"2008","unstructured":"Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, et al. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med. 2008;5(6):0890\u20139. https:\/\/doi.org\/10.1371\/JOURNAL.PMED.0050128. PubMed PMID: 18563962.","journal-title":"PLoS Med"},{"issue":"6874","key":"14383_CR17","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/415905A","volume":"415","author":"SI Hay","year":"2002","unstructured":"Hay SI, Cox J, Rogers DJ, Randolph SE, Stern DI, Shanks GD, et al. Climate change and the resurgence of malaria in the East African highlands. Nature. 2002;415(6874):905. https:\/\/doi.org\/10.1038\/415905A. PubMed PMID: 11859368.","journal-title":"Nature"},{"key":"14383_CR18","doi-asserted-by":"publisher","unstructured":"Geleta G, Ketema T. Severe malaria associated with Plasmodium falciparum and P. vivax among children in Pawe Hospital, Northwest Ethiopia. Malar Res Treat. 2016;2016. https:\/\/doi.org\/10.1155\/2016\/1240962. PubMed PMID: 27047701.","DOI":"10.1155\/2016\/1240962"},{"key":"14383_CR19","doi-asserted-by":"publisher","unstructured":"Ketema T, Bacha K. Plasmodium vivax associated severe malaria complications among children in some malaria endemic areas of Ethiopia. BMC Public Health. 2013;13(1). https:\/\/doi.org\/10.1186\/1471-2458-13-637. PubMed PMID: 23834734.","DOI":"10.1186\/1471-2458-13-637"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14383-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14383-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14383-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:05:31Z","timestamp":1790640331000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-14383-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14383"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-14383-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"2 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1724"}}